within Pharmacolibrary.Drugs.ATC.A;

model A03AB13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.08333333333333333,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Bevonium is an antimuscarinic (anticholinergic) drug historically used as a spasmolytic agent, chiefly for conditions involving gastrointestinal and urinary tract smooth muscle spasm. It is no longer widely used or approved in most countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameter estimates for bevonium are not available in the literature, and no peer-reviewed pharmacokinetic studies have been identified. The values below are estimated based on general pharmacokinetic properties of antimuscarinic agents administered orally.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A03AB13;
